Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catala Institute of Oncology
Hospital Germans Trias i Pujol
Barcelona, Spain
Ramesh K. Ramanathan, MD
Medical Director,
TGen Clinical Research Service
at Scottsdale Health Care,
Scottsdale, AZ
Clinical Professor of Medicine,
College of Medicine,
University of Arizona,
Phoenix, AZ
Other Expert Faculty
Svetomir N. Markovic, MD, PhD
Associate Professor of Oncology
Professor of Medicine
Mayo Clinic
Rochester, MN
Jeffrey R. Infante, MD
Associate Director of Drug Development
Sarah Cannon Research Institute
Nashville, TN
CO-CHAIRS
Rafael Rosell, MD, PhD
Chief, Medical Oncology Service
Scientific Director of Oncology Research
Catala Institute of Oncology
Hospital Germans Trias i Pujol
Barcelona, Spain
Ramesh K. Ramanathan, MD
Medical Director,
TGen Clinical Research Service at Scottsdale Health Care,
Scottsdale, AZ
Clinical Professor of Medicine,
College of Medicine,
University of Arizona,
Phoenix, AZ
DISCLOSURES AND RESOLUTION OF CONFLICTS OF INTEREST
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial Support, educational activities sponsored by the Oncology Learning Center (OLC) must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, and planning committee members participating in an OLC-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. All conflicts of interest will be resolved prior to the start of this symposium.
FACULTY/STAFF DISCLOSURE
Coming Soon.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration (FDA). The Oncology Learning Center (OLC) does not recommend the use of any agent outside of the FDA labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Oncology Learning Center. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
Educational Grant
Sincere appreciation is extended to Abraxis Oncology for their generous support of this educational meeting.
Contact Us
Oncology Learning Center 16415 Addison Rd., Suite 300
Addison, TX 75001 (214) 269 2014
1415 Legacy Drive, Suite 250 • Frisco, TX 75034 • Registration Phone: 214.269.2014 • Fax: 214.866.0311 Contact Us
Disclaimer: The material published on the Biomedical Learning Institute(BLI) Web site reflects the opinions and expertise of the authors and/or reviewers of the material, and not the opinions of the BLI, the CME provider, or the commercial supporters providing educational grants. The materials may address uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. Before using any therapeutic approaches reviewed in this material, a qualified physician should be consulted. Readers of this content should verify all information and data before treating patients or using any drugs or therapies described in any BLI materials. Click here for our Privacy Policy.
